Predictors for a positive reaction on a rTMS-treatment for patients with depressive disorder

被引：0
|
作者：
Piehl, Anja [1 ]
Richter, K. [1 ]
Scholz, F. [1 ]
Lehfeld, H. [1 ]
Niklewski, G. [1 ]
机构：
[1] Klin Psychiat & Psychotherapie, Nurnberg, Germany
来源：
NERVENARZT | 2007年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [31] MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    Dunlop, Katharine
    Gaprielian, Pauline
    Blumberger, Daniel
    Daskalakis, Zafiris J.
    Kennedy, Sidney H.
    Giacobbe, Peter
    Downar, Jonathan
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (102):
  • [32] Frontal EEG predictors of treatment outcome in major depressive disorder
    Iosifescu, Dan V.
    Greenwald, Scott
    Devlin, Philip
    Mischoulon, David
    Denninger, John W.
    Alpert, Jonathan E.
    Fava, Maurizio
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (11) : 772 - 777
  • [33] Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder
    Fonseka, Trehani M.
    MacQueen, Glenda M.
    Kennedy, Sidney H.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 233 : 21 - 35
  • [34] Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder
    Mamdani, Firoza
    Berlim, Marcelo T.
    Beaulieu, Marie-Martine
    Turecki, Gustavo
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (02): : 135 - 144
  • [35] Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder
    Judit Lazary
    Monika Elemery
    Peter Dome
    Szilvia Kiss
    Xenia Gonda
    Laszlo Tombor
    Laszlo Pogany
    Gergely Becskereki
    Blanka Toth
    Gabor Faludi
    Scientific Reports, 11
  • [36] Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder
    Lazary, Judit
    Elemery, Monika
    Dome, Peter
    Kiss, Szilvia
    Gonda, Xenia
    Tombor, Laszlo
    Pogany, Laszlo
    Becskereki, Gergely
    Toth, Blanka
    Faludi, Gabor
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [37] PREDICTORS FOR DULOXETINE TREATMENT FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN VETERANS AFFAIRS HEALTH CARE NETWORK
    Shi, L.
    Liu, J.
    Zhao, Y.
    VALUE IN HEALTH, 2009, 12 (07) : A365 - A365
  • [38] Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder
    Herrera-Guzman, Ixchel
    Gudayol-Ferre, Esteve
    Lira-Mandujano, Jennifer
    Herrera-Abarca, Jorge
    Herrera-Guzman, Daniel
    Montoya-Perez, Karina
    Guardia-Olmos, Joan
    PSYCHIATRY RESEARCH, 2008, 160 (01) : 72 - 82
  • [39] Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
    Lee, Jeong-Ok
    Kim, Ju-Wan
    Kang, Hee-Ju
    Hong, Jin-Pyo
    Kim, Jae-Min
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2018, 16 (04) : 461 - 468
  • [40] Associations between frontal lobe activity and depressive symptoms in patients with major depressive disorder receiving rTMS treatment: a near-infrared spectroscopy study
    Chou, Po-Han
    Liu, Wen-Chun
    Wang, Shao-Cheng
    Lin, Wei-Hao
    Chung, Yi-Lun
    Chang, Chun-Hung
    Su, Kuan-Pin
    FRONTIERS IN PSYCHIATRY, 2023, 14
12345